Cornel Iancu

Cornel Iancu

Auto-generated profile, based on publicly available information

Cornel Iancu

Reg Inst Gastroenterol & Hepatol, Dept Surg, Cluj Napoca, Romania

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
CMCristian T Matea
Cristian T Matea
TMTeodora Mocan
Teodora Mocan
FTFlaviu Tabaran
Flaviu Tabaran
TPTeodora Pop
Teodora Pop
OMOfelia Mosteanu
Ofelia Mosteanu
LMLucian Mocan
Lucian Mocan
Quantum dots (QDs), also known as nanoscale semiconductor crystals, are nanoparticles with unique optical and electronic properties such as bright and intensive fluorescence. Since most conventional organic label dyes do not offer the near-infrared (>650 nm) emission possibility, QDs, with their tunable optical properties, have gained a lot of interest. They possess characteristics such as good chemical and photo-stability, high quantum yield and size-tunable light emission. Different types of QDs can be excited with the same light wavelength, and their narrow emission bands can be detected simultaneously for multiple assays. There is an increasing interest in the development of nano-theranostics platforms for simultaneous sensing, imaging and therapy. QDs have great potential for such applications, with notable results already published in the fields of sensors, drug delivery and biomedical imaging. This review summarizes the latest developments available in literature regarding the use of QDs for medical applications.

23 May 2017 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
TMTeodora Mocan
Teodora Mocan
CMCristian T. Matea
Cristian T. Matea
TPTeodora Pop
Teodora Pop
OMOfelia Mosteanu
Ofelia Mosteanu
ABAnca Dana Buzoianu
Anca Dana Buzoianu
LMLucian Mocan
Lucian Mocan

31 March 2017 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
TMTeodora Mocan
Teodora Mocan
CMCristian-Tudor Matea
Cristian-Tudor Matea
TPTeodora Pop
Teodora Pop
OMOfelia Mosteanu
Ofelia Mosteanu
ABAnca Dana Buzoianu
Anca Dana Buzoianu
LMLucian Mocan
Lucian Mocan
Pathogenic bacteria contribute to various globally important diseases, killing millions of people each year. Various fields of medicine currently benefit from or may potentially benefit from the use of nanotechnology applications, in which there is growing interest. Disease-related biomarkers can be rapidly and directly detected by nanostructures, such as nanowires, nanotubes, nanoparticles, cantilevers, microarrays, and nanoarrays, as part of an accurate process characterized by lower sample consumption and considerably higher sensitivity. There is a need for accurate techniques for pathogenic bacteria identification and detection to allow the prevention and management of pathogenic diseases and to assure food safety. The focus of this review is on the current nanoparticle-based techniques for pathogenic bacterial identification and detection using these applications.

1 January 2014 in Journal of Cancer
Verified
Journal Article
Open access
TMTeodora Mocan
Teodora Mocan
CMCristian T. Matea
Cristian T. Matea
ICIulia Cojocaru
Iulia Cojocaru
IIIoana Ilie
Ioana Ilie
FTFlaviu Tabaran
Flaviu Tabaran
LMLucian Mocan
Lucian Mocan
Pancreatic cancer (PC) is one of the most lethal solid tumor in humans, with an overall 5-year survival rate of less than 5%. Thermally active carbon nanotubes have already brought to light promising results in PC research and treatment.

16 September 2009 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
PDF file
MMMeena Mahmood
Meena Mahmood
DCDaniel A. Casciano
Daniel A. Casciano
TMTeodora Mocan
Teodora Mocan
CICornel Iancu
Cornel Iancu
YXYang Xu
Yang Xu
ABAlexandru Biris
Alexandru Biris

31 January 2013 in Surgical Endoscopy
Verified
Journal Article
Open access
PDF file
FZFlorin Zaharie
Florin Zaharie
Dana IancuDana Iancu
Dana Iancu
LMLucian Mocan
Lucian Mocan
RZRoxana Zaharie
Roxana Zaharie
CICornel Iancu
Cornel Iancu
CTClaudiu Tomus
Claudiu Tomus
Background Selection of the most appropriate treatment to obtain the lowest morbidity, mortality, and recurrence rates is mandatory for hydatid disease of the liver. This study evaluated the results of laparoscopic treatment (compared with the open approach) in the context of a 10-year single-institution experience. Methods Between January 1998 and January 2008, 333 patients with hydatid disease of the liver underwent surgery in the authors’ department. Only the following aspects were considered as selection criteria for laparoscopic surgery: liver cyst not located in segment 1 or 7, with corticalization on the surface and no evidence of intrabiliary rupture. Of 62 patients who underwent laparoscopic treatment, 3 required conversion to open surgery. The remaining 59 patients (group 1) were analyzed. During the same period, 271 patients with hepatic hydatid disease underwent conventional surgery, but only 172 records were compatible with the criteria for the laparoscopic approach and the respective patients were retrospectively reviewed (group 2). Results Conversion to open surgery occurred in three cases (4.84 %). The mean cyst diameter was 6.62 cm (range, 2–15 cm) in group 1 and 7.23 cm (range, 2–18 cm) in group 2 (p = 0.699). The mean operative time was 72 min (range, 45–140 min) in group 1 and 65 min (range, 35–120 min) in group 2 (p < 0.001). The general complication rate and abdominal wound complication rate were respectively 0 % and 0 % in group 1 (p = 0.023) compared with 5.23 and 8.72 % in group 2 (p = 0.015). The mean hospital stay was 6.42 days (range, 1–21 days) in group 1 and 11.7 days (range, 4–80 days) in group 2 (p < 0.001). The mean follow-up period was 24.2 months (range, 6–32 months) in group 1 and 28.4 months (range, 6–40 months) in group 2. No recurrences were observed in either group during this period. Conclusion Laparoscopic surgery provides a safe and efficacious approach for almost all types of hepatic hydatid cysts. Large, prospective, randomized trials are needed to confirm its superiority.